Longitudinal analysis of Plasmodium falciparum genetic variation in Turbo, Colombia: implications for malaria control and elimination by Chenet, Stella (ASU author) et al.
Chenet et al. Malar J  (2015) 14:363 
DOI 10.1186/s12936-015-0887-9
RESEARCH
Longitudinal analysis of Plasmodium 
falciparum genetic variation in Turbo, Colombia: 
implications for malaria control and elimination
Stella M. Chenet1, Jesse E. Taylor2, Silvia Blair3, Lina Zuluaga3 and Ananias A. Escalante4*
Abstract 
Background: Malaria programmes estimate changes in prevalence to evaluate their efficacy. In this study, parasite 
genetic data was used to explore how the demography of the parasite population can inform about the processes 
driving variation in prevalence. In particular, how changes in treatment and population movement have affected 
malaria prevalence in an area with seasonal malaria.
Methods: Samples of Plasmodium falciparum collected over 8 years from a population in Turbo, Colombia were 
genotyped at nine microsatellite loci and three drug-resistance loci. These data were analysed using several popula-
tion genetic methods to detect changes in parasite genetic diversity and population structure. In addition, a coales-
cent-based method was used to estimate substitution rates at the microsatellite loci.
Results: The estimated mean microsatellite substitution rates varied between 5.35 × 10−3 and 3.77 × 10−2 substitu-
tions/locus/month. Cluster analysis identified six distinct parasite clusters, five of which persisted for the full duration 
of the study. However, the frequencies of the clusters varied significantly between years, consistent with a small effec-
tive population size.
Conclusions: Malaria control programmes can detect re-introductions and changes in transmission using rapidly 
evolving microsatellite loci. In this population, the steadily decreasing diversity and the relatively constant effective 
population size suggest that an increase in malaria prevalence from 2004 to 2007 was primarily driven by local rather 
than imported cases.
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Background
During the 1970s and 1980s, malaria incidence increased 
in South America due to the disorganized development 
of cities and the emergence of drug resistance in Plasmo-
dium falciparum [1, 2]. However, during the last 10 years, 
transmission has decreased and many areas exhibit lim-
ited spatial connectivity between parasite populations 
[3]. As a result of this tangible reduction in transmission, 
malaria control programmes in these areas are expected 
to change from the control to the elimination phase.
Previous studies of P. falciparum in South America 
identified strong genetic structure and epidemic expan-
sions that were the result of inbreeding and bottlenecks 
due to high drug pressure [4–7]. As a result, parasite 
populations within this region exhibit high genetic dif-
ferentiation. Regardless of these discoveries, there have 
been few attempts to incorporate information on para-
site genetic diversity into control programmes [8–12]. 
A recent example is the study by Daniels et  al. in Sen-
egal [11]. This study illustrated how genetic informa-
tion obtained by using SNPs on P. falciparum samples 
collected over an 8 years period enriched epidemiologi-
cal information [11, 12]. In particular, the authors could 
detect genetic changes in the parasite population that 
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correlated with field data by using epidemiological mod-
els [11].
In this paper, the relationship between parasite genetic 
variation and malaria epidemiology is explored in a 
locality that has seen substantial fluctuations in malaria 
prevalence. This study was conducted on samples col-
lected over 8  years in the northwest region of Colom-
bia, one of the most malaria-endemic countries in South 
America [13]. Due to economic activities, such as mining 
and agriculture, there is substantial migration of workers 
with very high exposure to malaria (in close proximity to 
Anopheles sp. breeding sites) into different towns. These 
local movements are considered important in the main-
tenance of malaria transmission in Colombia and other 
similar settings in the Americas [1, 14]. Samples were 
genotyped at several microsatellite loci and analysed 
using Bayesian coalescent methodologies that have been 
successfully applied to other human pathogens [15–17]. 
In contrast to cross-sectional studies, genetic data from 
longitudinal historical samples can be used to separately 
estimate the effective population size (Ne) and substi-
tution rate at each locus. In addition, other mutations 
associated with drug resistance in P. falciparum were 
explored to determine how their frequency changed after 
the drugs were no longer in use.
Methods
Plasmodium isolates
A total of 257 P. falciparum blood samples collected on 
filter paper between 2002 and 2009 from surveillance 
studies carried out in Turbo (Antioquia department, 
Colombia) were genotyped: 94 samples were collected 
between October 2002 and July 2003, 80 from January 
2004 to December 2005, 47 between April and October 
2007, and 36 between March 2008 and July 2009. All 
samples came from P. falciparum-positive patients diag-
nosed by blood smear that gave their consent to partici-
pate in therapeutic efficacy studies at their local hospital 
[14, 18]. The samples used were those collected prior 
treatment [14, 18]. The inclusion criteria for the partici-
pants were: (a) patients that were older than 1  year of 
age with fever that lasted 48 h, (b) the patients were liv-
ing permanently in the study site, and (c) none had severe 
malaria or were pregnant. The exclusion criteria were: 
(a) having another associated disease requiring addi-
tional treatment, (b) having mixed Plasmodium vivax 
and P. falciparum infections, (c) being hypersensitive to 
anti-malarial drugs, (d) moving to another site different 
from that where the study was conducted, (e) voluntary 
withdrawal from the study, (f ) and third-party adminis-
tration of anti-malarial drugs [19]. All patients received 
treatments approved by the Colombian authorities for 
uncomplicated malaria at the time: amodiaquine (AQ) 
plus sulfadoxine-pyrimethamine (SP) until 2006, artesu-
nate (AS) plus mefloquine (MQ) in 2007, and artemether 
plus lumefantrine (LF) (Coartem®) from 2008 forward.
DNA isolation and genotyping methods
DNA was isolated using the QIAamp DNA mini kit 
(QIAGEN, Valencia, CA, USA) and whole genome ampli-
fication was performed using the Repli-g Mini Kit (QIA-
GEN, Valencia, CA, USA). Twelve neutral microsatellites 
distributed across seven chromosomes were used in this 
study [19]. Fluorescent-labelled PCR products were sepa-
rated on an Applied Biosystems 3730 capillary sequencer 
and scored using Gene Marker v1.95 (SoftGenetics LLC). 
The discovery of more than one allele in a sample was 
interpreted as a multiclonal infection. Missing data (no 
amplifications) were reported by locus but not consid-
ered for defining haplotypes.
The samples were also genotyped by direct sequenc-
ing to evaluate mutations at Pfcrt (codons 72–76), Pfd-
hfr (codons 50, 51, 59, 108, and 164) and Pfdhps (codons 
436, 437, 540, 581, and 613) which have been associ-
ated with chloroquine, pyrimethamine, and sulfadoxine 
resistance, respectively. Only samples from single infec-
tions as determined by neutral microsatellite loci were 
sequenced. The PCR primers and conditions for Pfcrt, 
Pfdhfr and Pfdhps have been previously described [20, 
21]. In addition, all samples were assayed for 15 microsat-
ellite loci that span 129 Kb on chromosome 4 around Pfd-
hfr, 15 loci that span 139  Kb on chromosome 9 around 
Pfdhps [22] and ten loci that span 500  Kb on chromo-
some 7 around Pfcrt [20].
Population genetic analyses
Genetic variation at each locus was quantified by the 
allelic diversity, which was estimated using the for-
mula HE = [n/(n− 1)]
[
1−
∑L
i=1 p
2
i
]
, where n is 
the number of isolates sampled and pi is the fre-
quency of the ith allele (i  =  1, …, L) in the sam-
ple. The sampling variance for HE was calculated 
as 2(n− 1)/n3[2(n− 2)]
[∑L
i=1 p
3
i −
(∑L
i=1 p
2
i
)2]
 [23]. 
To assess the parasite population structure, the genetic 
data was analysed with Structure v2.1 [24], which uses 
a Bayesian clustering algorithm to assign isolates to a 
fixed number (K) of populations or clusters. The data 
were evaluated using different K values (K  =  2–10) 
and ten independent chains were run for each K value 
with a burn-in period of 10,000 iterations followed by 
50,000  iterations. The admixture model was used in 
all cases, allowing for the presence of individuals with 
ancestry in two or more of the K populations. The popu-
lation was also described using median-joining networks 
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inferred by Network 4.6.1.1 [25] on neutral and linked 
microsatellite data. The standardized index of association 
(IS
A
) was also used to test for evidence of overall multi-
locus linkage disequilibrium in the population per year 
[26]. FST values were calculated using Arlequin 3.11 [27].
Bayesian phylogenetic analyses: microsatellite substitution 
rates and phylodynamics
Microsatellites can gain and lose repeats by two different 
mechanisms: unequal crossing over and DNA-replication 
slippage [28]. Bayesian coalescent-based method imple-
mented in BEAST v.1.7.5 [29] were used to compare 12 
models of microsatellite evolution, which make different 
assumptions about the relationship between the expan-
sion and contraction rates and the repeat length [30]. 
In addition, the mean substitution rate at each locus in 
units of absolute time was estimated. The tip dates (sam-
pling dates) were recorded in months and the coalescent 
constant population size model was used with a strict 
molecular clock and a standard uniform prior on the 
mean substitution rate. Once all 12 microsatellite muta-
tion models had been run in this fashion, the model best 
supported by the data was identified by calculating the 
Bayes’ factor for each model relative to a reference model 
and choosing the one with the largest factor.
The best supported substitution model and the cor-
responding substitution rate were used in an Extended 
Bayesian Skyline Plot (EBSP)  to estimate the parasite 
effective population size (Ne) through time, assuming a 
generation time for malaria infections of a month. The 
EBSP assumes a non-parametric piecewise linear model 
of population size and uses information from multiple 
unlinked neutral loci to estimate the number of popula-
tion size changes. Each analysis was performed with three 
independent runs based on 8 × 108 generations and sam-
ples taken every 1 ×  106 steps after a burn-in period of 
20 %. Convergence of the Markov chains was assessed by 
monitoring both the trace plots and effective sample sizes.
Results
Genotyping of neutral microsatellite loci
A total of 245 out of 257 samples amplified at 11 out of 
the 12 loci. Nine loci were retained for further analy-
sis due to their clear pattern on the electropherogram 
(single peak) that facilitated the identification of alleles 
(Additional file 1). Of these, five exhibited high levels of 
variation (Additional file 1). Although 57 multiple infec-
tions were detected, 90 % of these were variable at only 
one locus suggesting that these patients were infected 
by highly related parasites (Table 1). A total of 79 differ-
ent multi-locus genotypes were identified and analysed 
(Additional file  2), those included four genotypes that 
were found in at least six consecutive years following 
2003 (Additional file 2). However, most pairwise fixation 
indices calculated between samples collected in differ-
ent years were significantly different from zero (Table 2), 
indicating substantial changes in the genetic composition 
of the parasite population between years. Genetic diver-
sity (HE =  0.35 ±  0.11, Table 1) was highest in samples 
collected in 2002, with 93.3  % of infections caused by 
different lineages, after which HE steadily declined in all 
years except 2008. Several unique haplotypes were found 
in low frequency each year (Additional file  3). Finally, 
analysis of the microsatellite data using the index of 
association statistic detected significant multilocus link-
age disequilibrium (LD) in every year (IS
A2003
  =  0.058, 
p < 0.01; IS
A2004
 = 0.056, p < 0.01; IS
A2005
 = 0.14, p < 0.01, 
I
S
A2007
  =  0.072, p  <  0.01; IS
A2008
  =  0.143, p  <  0.01; 
I
S
A2009
  =  0.163, p  <  0.01) except 2002, possibly because 
of the small number of samples collected that year. Sig-
nificant genetic differences between samples per year are 
shown in Table 2.
Genotyping of Pfcrt, Pfdhfr and Pfdhps
Most of the samples were double mutants (75E and 76T) 
for Pfcrt. There was also one triple mutant (74I, 75E and 
Table 1 Plasmodium falciparum genetic diversity per year
a Total number of multiple infections with lineages that differed at one or more loci
b Number (percentage) of different haplotypes in the total number of samples
c Unique haplotypes found per year
Year Number 
of cases
Sample  
size
Multiple  
infectionsa (%)
Haplotypesb (%) Unique  
hapsc
He SD Number of  
alleles
SD
2002 864 15 3 (20) 14 (93.3) 9 0.35 0.11 2.44 1.24
2003 406 79 19 (24.1) 32 (40.5) 17 0.31 0.09 3 1.12
2004 365 40 11 (27.5) 23 (57.5) 11 0.29 0.1 2.44 1.74
2005 349 31 6 (19.4) 16 (51.6) 6 0.28 0.09 2.11 1.62
2007 856 46 10 (21.7) 15 (32.6) 8 0.22 0.08 3 1.41
2008 220 20 3 (15) 9 (45) 4 0.25 0.07 2.44 0.88
2009 154 14 5 (35.7) 5 (35.7) 0 0.18 0.07 2.33 0.71
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76T) and one sensitive (wild type) genotype in the 2007 
samples. For Pfdhfr, pyrimethamine resistance-associ-
ated mutations N51I and S108N were found in all sam-
ples except in one, also from the 2007 group. For Pfdhps, 
only sensitive and single mutant A437G genotypes were 
found. These drug-resistant genotypes appeared to be 
conserved over time (around 85  % of the samples from 
each year had the Pfdhps SGKAA genotype) regardless of 
the turnover of lineages revealed by neutral microsatel-
lites. The allelic variation in the microsatellite loci flank-
ing these resistance genes was also explored and found 
29 different haplotypes for Pfcrt, 28 for Pfdhfr and 29 for 
Pfdhps (Additional files 4, 5, 6).
Cluster analysis
Six clusters were identified, most of which persisted 
for several years (Fig.  1a; Table  3). While all six clus-
ters were found in samples from 2002 to 2003, only five 
were detected in samples from 2007 to 2009, and a clear 
expansion of cluster D was observed in 2005. In con-
trast, cluster E was not detected in 2007, 2008 or 2009, 
and may have suffered a random local extinction during 
a period when the parasite population size was reduced 
following the introduction of AQ.
The software Network version 4.6.1.1 was used to 
characterize the relationship between multilocus geno-
types (Fig. 1b) and those clusters that persisted for sev-
eral years. Genotypes assigned to cluster F were highly 
dispersed in the network without a clear grouping pat-
tern. One sample was distantly related to the rest of the 
network and had a sensitive genotype for Pfcrt, Pfdhps 
and Pfdhfr, which is present in Central America. Addi-
tionally, haplotype networks were constructed using the 
microsatellite loci flanking the drug resistance genes. 
The haplotypes associated with the Pfdhps mutant were 
grouped together, while the haplotypes associated with 
the wild type Pfdhps genotype were highly dispersed 
throughout the network (Fig.  2). This pattern was not 
observed in Pfcrt and Pfdhfr where the resistant geno-
types were fixed.
Time estimation and mutation rates
A total of 12 different microsatellite mutation models 
implemented in BEAST v1.7.5 were tested and the PL1 
was the best supported model at each of the nine neutral 
loci included in this study (Table  4). Under this model, 
the substitution rate is linearly proportional to microsat-
ellite length (P), the probability of microsatellite contrac-
tion is different from expansion but dependent on allele 
length (L), and each mutation changes the length of the 
microsatellite by exactly one repeat (1). Consequently, 
PL1 was used in all subsequent analyses conducted using 
BEAST. The mean substitution rate was estimated at 
each of these loci, which varied between 5.35 × 10−3 and 
3.77 × 10−2 substitutions/month for the six most variable 
loci (mean of the posterior distribution; Table 5). Surpris-
ingly, somewhat higher rates were estimated at three loci 
that harbored little variation, but the 95 % highest prob-
ability density (HPD) intervals were also much broader at 
these loci than at the other six, suggesting low informa-
tion content in the data and greater influence of the prior 
distribution on the substitution rate.
Examination of the extended Bayesian skyline plot 
(EBSP; Fig. 3) reveals that there is little correspondence 
between the estimated Ne (assuming a generation time 
of a month) and the number of monthly cases reported 
from 2002 to 2009 to the Antioquia Sectional Health 
Directorate (Dirección Seccional de Salud de Antioquia), 
Colombia. Neither the short-term fluctuations nor the 
longer-term trends seen in the monthly case data are evi-
dent in the EBSP. Furthermore, while the estimated Ne is 
several times smaller than the number of monthly case 
reports in most months between January 2002 and Janu-
ary 2007, the opposite pattern is seen in the period 2007 
to 2009 when there was a pronounced decrease in the 
number of reported cases but also slight increase in the 
estimated effective population size.
Discussion
The prevalence of P. falciparum malaria in Turbo, 
Colombia fluctuated dramatically between 2003 and 
Table 2 Microsatellite-based genetic differentiation (Fst) between years
*P value <0.05
Year 2002 2003 2004 2005 2007 2008
2003 0.08*
2004 0.20* 0.07*
2005 0.19* 0.11* 0.11*
2007 0.27* 0.18* 0.19* 0.27*
2008 0.18* 0.08* 0.09* 0.19* 0.08*
2009 0.29* 0.15* 0.15* 0.29* 0.02 0.02
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2010 (Fig. 3). These demographic changes were contem-
poraneous with changes in treatment protocols, which 
saw the adoption of new drug therapies in 2002, 2007 and 
2008. However, as can be seen in Table 1a, the relation-
ship between the treatment protocol and annual malaria 
prevalence is not simple. For example, whereas the switch 
to AS + MQ in 2007 had little immediate impact on the 
number of reported cases, the switch to COARTEM in 
2008 coincided with a sharp decline in the number of 
cases, which decreased from 856 in 2007 to 220 in 2008.
To better understand the processes influencing P. fal-
ciparum malaria in this region, this study involved the 
characterization of this parasite population using a 
combination of neutral microsatellite markers and loci 
linked to known drug resistance mutations at three loci. 
Because these two classes of loci are expected to differ in 
both their mutation rates and exposure to selection, they 
have the potential to reveal different features of malaria 
epidemiology.
The analysis of the microsatellite data revealed the 
existence of several related multilocus genotypes that 
persisted for at least 6 years in the region around Turbo 
(Fig.  1; Additional file  2). This is the pattern expected 
in a parasite population where control efforts have left 
behind lineages that became the founders of clusters of 
highly related parasites [7, 10]. This observation differs 
from a previous study of a Plasmodium population in 
Peru which found that multilocus genotypes were rapidly 
2002 2003 2004 2005 2007 2008 2009
K=6
a
b
Cluster A
Cluster B
Cluster C
Cluster D
Cluster E
Cluster F
Migrant
Fig. 1 Population structure using neutral microsatellite loci. a Clustering per year using Structure 2.3. Each colour represents a different population 
cluster. b Median joining haplotype network. The haplotypes are represented by circles with width being proportional to their frequencies. The links 
are character differences and the red circles represent median vectors required to connect sequences within the network with maximum parsimony
Table 3 Microsatellite-based genetic differentiation (Fst) 
between clusters
*P value <0.05
A B C D E
B 0.08*
C 0.05* 0.11*
D 0.18* 0.15* 0.31*
E 0.08* 0.09* 0.17* 0.12*
F 0.02* 0.07* 0.00 0.24* 0.10*
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broken down by recombination even in low-transmis-
sion areas [31]. Furthermore, all of the multilocus clus-
ters detected in the final year of this study (2009) were 
also represented in 2002, suggesting that there was little 
immigration of novel parasite genotypes from outside of 
the region.
In low-transmission areas, meiotic recombination is 
most likely to occur between lineages that are closely 
related, leading to high levels of inbreeding. This is con-
sistent with the fact that many of the putatively multiple 
infections identified in our sample vary at a single locus, 
possibly due to mitotic mutations that have occurred 
within the infected individual. Such mitotic events can 
lead to an overestimation of the number of observed 
multiple infections [8]. Inbreeding can also account for 
the significant levels of multilocus linkage disequilibrium 
documented in every year except 2002 (see “Results”). 
On the other hand, the microsatellite data suggests that 
there has been some recombination among the differ-
ent clusters segregating in Turbo, as is evidenced by the 
admixture patterns seen in the cluster analysis (Fig. 1).
Although several multilocus haplotypes were observed 
to persist for multiple years, the cluster analysis revealed 
pronounced changes in the genetic composition of the 
P. falciparum population in Turbo from year to year, 
with different clusters dominant in different years. This 
observation is confirmed by the pairwise fixation indi-
ces shown in Table 2, which show significant genetic dif-
ferentiation between every pair of years except between 
2009 (when only 14 individuals were sampled) and the 
Fig. 2 Median joining haplotype network using Pfdhps-linked microsatellites. The haplotypes are represented by circles with width being propor-
tional to their frequencies. Haplotypes in the red dashed circle are single mutants grouped in colour clusters according to their genotypes (using 
Structure). Haplotypes in green are wild type genotypes
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preceding 2 years. Rapid non-directional changes in the 
genetic composition of a population, such as observed 
here, can be explained by demographic stochasticity (i.e., 
genetic drift), which is expected to be pronounced in 
small populations. This is consistent with the low effec-
tive population size revealed by the EBSP (Fig. 3).
There is a lack of a correspondence between the esti-
mated Ne displayed by the EBSP (using the posterior 
median of the EBSP) and the monthly case reports. Dur-
ing 2003 to 2007, Ne remained relatively unchanged even 
though there were substantial fluctuations in prevalence. 
Furthermore, between 2007 and 2009 there was a grad-
ual rise in Ne even though the number of monthly case 
reports rapidly decreased following 2008. The reduction 
in cases coincides with an intense malaria control pro-
gramme known as “Papa Luis” carried out in Antioquia 
between 2007 and 2009. This programme consisted of 
massive administration of chloroquine (an effective drug 
to treat P. vivax but not P. falciparum), biological control 
of Anopheles larvae, swamp drainage and indoor residual 
spraying [32]. During this period, the introduction of 
artemisinin-based combination therapy (ACT) is also 
thought to have contributed to a reduction in malaria 
cases.
The discrepancy between the epidemiological and 
genetic estimates could be explained by several factors. 
For parasites, Ne depends not only on prevalence, but also 
on the transmission rate and the variance in the number 
of new cases transmitted by infected individuals [9, 10, 
33, 34]. In particular, a fixed parasite generation time of 
1 month was assumed for the study, but the time between 
transmission events could vary affecting the parasite gen-
eration time. Similarly, the number of new cases gener-
ated by infected individuals can vary over time due to 
changes in social dynamics or public health policy and 
this too will affect Ne. The observation that during 2003 
to 2007, Ne remained relatively unchanged even though 
there were substantial fluctuations in prevalence suggests 
that seasonal clonal expansions led to a high prevalence 
at some time points. Indeed, frequent clonal expansions 
could even reduce Ne if they were accompanied by an 
increase in either the transmission rate or the transmis-
sion variance between infected individuals.
Another factor that may have contributed to the mis-
match between the estimated values of Ne and the case 
report numbers is the variation in the sample sizes col-
lected for genetic analysis in different years. In particu-
lar, the apparent rise in the estimated Ne from 2007 to 
2009 may be due to the smaller number of samples col-
lected in these years compared with the period 2003 to 
2006. One consequence of the variable sample sizes is 
that the posterior distribution of the effective population 
size is more strongly influenced by the prior distribu-
tion in those periods when the data are less informative. 
Indeed, this is evident in the increasing credibility inter-
vals for Ne between 2007 and 2009. Because of this sen-
sitivity to sample sizes, archiving samples for genotyping 
should be a standard policy since those will facilitate 
understanding potential re-introductions or changes in 
prevalence.
Table 4 Models of  microsatellite evolution using neutral 
microsatellite loci
a PC1 model was not included due to lack of convergence
b Bayes factors were computed relative to model PL1 using the formula: 
B.F.(X) = P(model PL1|data)/P(model X|data)
Mutation modela ln P (model|data) SE log10 (Bayes factor)
b
EU1 −293.01 ±1.986 11.330
EU2 −302.502 ±2.594 15.420
EC1 −270.358 ±2.919 1.492
EC2 −300.767 ±1.168 14.698
EL1 −289.253 ±1.263 9.698
EL2 −322.453 ±2.943 24.116
PU1 −303.904 ±2.57 16.000
PU2 −315.611 ±3.152 21.145
PC2 −802.399 ±67.545 9.644
PL1 −266.923 ±0.732 0.000
PL2 −328.27 ±4.27 26.643
Table 5 Average microsatellite substitution rates (events/month) estimated using the PL1 model implemented in BEAST
The migrant haplotype was excluded from calculations
Loci POLYa TA60 ARA2 Pfg377 PfPK2 TA109 TA81 TA42 2490
Global He 0.57 0.0078 0.58 0 0.65 0.0078 0.48 0.03 0.52
Mean 3.77E−02 0.1393 1.06E−02 0.2046 3.25E−02 0.4292 5.35E−03 8.00E−03 2.18E−02
Std err of mean 1.11E−03 4.75E−03 3.89E−04 7.57E−03 7.09E−04 2.19E−02 1.26E−04 3.77E−04 5.91E−04
Median 3.40E−02 8.97E−02 9.57E−03 0.1424 3.00E−02 0.3233 4.72E−03 6.39E−03 1.99E−02
95 % HPD lower 9.01E−03 6.40E−04 1.78E−03 2.86E−03 1.04E−02 5.20E−05 8.26E−04 1.42E−04 4.68E−03
95 % HPD upper 7.37E−02 0.4273 2.13E−02 0.5831 6.09E−02 1.1515 1.16E−02 2.07E−02 4.29E−02
Effective sample size (ESS) 275.038 1230.751 202.309 794.978 393.838 322.162 595.85 286.73 335.739
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The genetic data from samples collected over a span 
of 8  years also allowed to estimate microsatellite sub-
stitution rates separately from Ne. At the six polymor-
phic loci with enough information, estimates ranged 
from 5.35 × 10−3 to 3.77 × 10−2 substitutions per locus 
per month (Table 5). In contrast, Su et  al. estimated a 
genome-wide average microsatellite mutation rate of 
1.59 × 10−4 per locus per meiosis from a genetic cross 
that was typed at 901 loci [35]. Notably, this rate falls 
below the 95 % HPD interval of five of the six loci that 
were investigated. The large discrepancy between these 
estimates could be due to two differences between the 
studies. First, whereas Su et al. only considered changes 
arising during meiosis, the estimates reported here 
reflect the accumulation of mutations over month-
long periods during which the parasite is likely to have 
undergone multiple mitoses and at most one or two 
meioses. For the purposes of demographic/epidemio-
logic inferences, this composite rate is more relevant 
than the meiotic mutation rate. Secondly, locus-spe-
cific variation in microsatellite substitution rates could 
also explain this discrepancy. Since variable loci were 
chosen, those may be evolving more rapidly than the 
genome-wide pool of loci analysed by Su et al.
It should be noted that the mean substitution rates 
reported in this paper were obtained using the model 
best supported by our data, the single-phase proportional 
linear model (PL1). There was no support for any of the 
two-phase models of microsatellite evolution imple-
mented in BEAST in which alleles may expand or con-
tract by more than one repeat in a single step, although 
this too could be specific to the loci analysed in this study. 
The PL1 model assumes that the overall substitution rate 
is proportional to the repeat length, that each mutation 
results in the gain or loss of a single repeat, and that the 
probability of an expansion is a decreasing linear function 
of the repeat length, so that above a certain threshold, 
mutations are more likely to result in a contraction rather 
than in an expansion of the microsatellite [30]. As such, 
the rates reported in Table  5 are estimates of the mean 
substitution rate with respect to the stationary distribu-
tion of the microsatellite length under this model. These 
estimates provide empirical evidence that polymorphic 
microsatellite loci can be used to make inferences at time 
scales that are epidemiologically relevant [36].
Lastly, although drug resistance mutations can decrease 
in frequency once the corresponding drugs are no longer 
in use [37, 38], there are also endemic areas where such 
mutations have gone to fixation from intermediate fre-
quencies even after drug pressure has been removed [4, 5, 
20]. This study provides evidence of this process. Moreo-
ver, the data show that drug resistance mutations were 
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Fig. 3 Comparison of the effective population size for Plasmodium falciparum with the number of reported cases in Turbo. The parasite generation 
time is assumed to be equal to a month. The mean and the 95 % HPD of the effective population size (Ne) estimated by the EBSP are represented by 
the blue and enclosing grey lines, respectively. The monthly number of P. falciparum cases in Turbo is represented by a dashed black line with changes 
in treatment regimen indicated by red dashed vertical lines (amodiaquine (AQ) plus sulfadoxine–pyrimethamine (SP), artesunate (AS) plus meflo-
quine (MQ), and artemether plus lumefantrine (Coartem®)
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fixed in a parasite population with a low effective popula-
tion size and then remained at high frequency even after 
the drug policy was changed. Thus, anti-malarial drugs 
will remain ineffective unless there is an influx of sensi-
tive parasites from other areas (e.g., Central America). 
The finding of a sensitive and genetically unrelated para-
site demonstrates that such re-introductions are possible. 
It is worth noting that sensitive Pfdhps genotypes were 
still segregating in the population.
Conclusion
This study provided an opportunity to observe changes 
in the genetic composition of a local Plasmodium popu-
lation over many parasite generations. Several multilo-
cus genotypes were found to be stable for many years, a 
dynamic that should be considered when genotyping is 
used to separate local from re-introduced cases in areas 
with seasonal or low malaria transmission. The estimated 
substitution rates reported in this study support previ-
ous claims that polymorphic microsatellite loci evolve 
on a timescale that facilitates epidemiologic investiga-
tions. Regardless of spikes in prevalence followed by the 
scale-up of interventions and/or changes in drug policy, 
the parasite effective population size remained small and 
relatively unchanged for many years. This suggests that 
the observed fluctuations in the number of cases were 
likely the result of local processes (e.g. operational or 
environmental factors) that affected malaria transmis-
sion. Such processes will be better understood by incor-
porating genetic data into epidemiological models [11]. 
Furthermore, mutations associated with drug resist-
ance remained fixed in the population demonstrating 
that, without the influx of sensitive migrants, drugs will 
likely remain ineffective in endemic areas with similar 
epidemiologic characteristics such as the one studied 
here. Although several factors could affect the number 
of malaria cases, variation in the genetic composition of 
Plasmodium populations provides additional information 
that can facilitate the understanding of such changes and, 
by so doing, support science-based decision making pro-
cess regarding malaria control policies.
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